HC2 (HCHC) Getting Positive Press Coverage, Analysis Shows

News stories about HC2 (NYSE:HCHC) have trended positive on Thursday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. HC2 earned a coverage optimism score of 0.27 on Accern’s scale. Accern also gave headlines about the technology company an impact score of 46.7633716194306 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

HC2 (NYSE HCHC) traded up $0.02 during mid-day trading on Thursday, reaching $6.27. The company had a trading volume of 167,500 shares, compared to its average volume of 140,009. The stock has a market capitalization of $269.09, a PE ratio of -2.43 and a beta of 0.66. HC2 has a 12-month low of $4.30 and a 12-month high of $7.27. The company has a debt-to-equity ratio of 6.06, a quick ratio of 1.34 and a current ratio of 1.34.

HC2 (NYSE:HCHC) last posted its earnings results on Wednesday, November 8th. The technology company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.07). The business had revenue of $406.40 million for the quarter, compared to analysts’ expectations of $428.04 million. HC2 had a negative return on equity of 67.69% and a negative net margin of 6.13%. HC2’s revenue for the quarter was down 1.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.20) EPS. research analysts predict that HC2 will post -1.11 EPS for the current fiscal year.

Several brokerages have recently issued reports on HCHC. Zacks Investment Research upgraded HC2 from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. B. Riley reiterated a “buy” rating and issued a $11.50 price objective (up previously from $10.00) on shares of HC2 in a research note on Tuesday, November 7th.

In related news, insider Suzi R. Herbst sold 5,303 shares of the business’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $4.99, for a total transaction of $26,461.97. Following the completion of the sale, the insider now owns 27,493 shares in the company, valued at $137,190.07. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert V. Leffler, Jr. sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $5.00, for a total value of $100,000.00. Following the sale, the director now owns 19,779 shares of the company’s stock, valued at approximately $98,895. The disclosure for this sale can be found here. 16.00% of the stock is owned by insiders.

COPYRIGHT VIOLATION WARNING: “HC2 (HCHC) Getting Positive Press Coverage, Analysis Shows” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/01/18/hc2-hchc-getting-positive-press-coverage-analysis-shows.html.

HC2 Company Profile

HC2 Holdings, Inc engages in construction, marine services, insurance, telecommunications, energy, life sciences, and other businesses in the United States, the United Kingdom, and internationally. The company fabricates and erects structural steel for commercial and industrial construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, and power plants.

Insider Buying and Selling by Quarter for HC2 (NYSE:HCHC)

Receive News & Ratings for HC2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HC2 and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply